Physician profile
Saurabh Malhotra
NPI 1033304431
$437,800.58
in general payments reported to CMS, 2019-2025
18 companies · $153K in 2025
The $153K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $16K · 2021: $16K · 2022: $48K · 2023: $40K · 2024: $133K · 2025: $153K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $249K · Consulting Fee: $37K · Travel and Lodging: $30K · Food and Beverage: $9,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $249,085.78 |
| Consulting Fee | $37,093.25 |
| Travel and Lodging | $29,950.52 |
| Food and Beverage | $9,411.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $202,409.78 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $151,308.20 | 2020-2025 | Amvuttra, Onpattro |
| Astrazeneca Pharmaceuticals Lp | $41,109.53 | 2021-2025 | Wainua |
| Bridgebio Pharma, INC. | $31,156.52 | 2025 | Attruby |
| Akcea Therapeutics, INC. | $5,444.62 | 2019-2021 | |
| Canon Medical Systems USA, INC. | $3,000.00 | 2020 | |
| Boston Scientific Corporation | $991.75 | 2021-2025 | Watchman Access System, Watchman |
| Abbott Laboratories | $812.92 | 2022-2025 | Cardiomems, Mitraclip |
| Penumbra, INC. | $397.51 | 2021-2024 | Indigo System |
| Abiomed | $266.26 | 2023-2024 | Impella |
| Astellas Pharma US INC | $198.95 | 2022 | |
| Inari Medical, INC. | $195.59 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $164.52 | 2025 | Flowtriever |
| Medicure Pharma INC. | $153.13 | 2022 | |
| Ge Healthcare | $149.75 | 2023-2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daxor Corporation | $22.14 | 2025 | Bva-100 |
| Edwards Lifesciences Corporation | $19.41 | 2025 | Sapien 3 Ultra Resilia |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saurabh Malhotra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.